Reduced phosphorylation of the mTOR signaling pathway components in the amygdala of rats exposed to chronic stress.
about
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressantsα-Linolenic Acid, A Nutraceutical with Pleiotropic Properties That Targets Endogenous Neuroprotective Pathways to Protect against Organophosphate Nerve Agent-Induced NeuropathologySynaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.mTORC1 Is a Local, Postsynaptic Voltage Sensor Regulated by Positive and Negative Feedback Pathways.Activation of D1R/PKA/mTOR signaling cascade in medial prefrontal cortex underlying the antidepressant effects of l-SPD.Gene expression analysis of novel genes in the prefrontal cortex of major depressive disorder subjects.AMPAkines have novel analgesic properties in rat models of persistent neuropathic and inflammatory pain.Neuroplasticity underlying the comorbidity of pain and depressionExogenous Tryptophan Promotes Cutaneous Wound Healing of Chronically Stressed Mice through Inhibition of TNF-α and IDO Activation.Phosphodiesterase-4D Knock-down in the Prefrontal Cortex Alleviates Chronic Unpredictable Stress-Induced Depressive-Like Behaviors and Memory Deficits in MicePersistent pain alters AMPA receptor subunit levels in the nucleus accumbensBranched-Chain Amino Acids as New Biomarkers of Major Depression - A Novel Neurobiology of Mood Disorder.Fluoxetine regulates mTOR signalling in a region-dependent manner in depression-like miceThe Role of Neurotrophins in Major Depressive Disorder.Predictable chronic mild stress in adolescence increases resilience in adulthood.Previous history of chronic stress changes the transcriptional response to glucocorticoid challenge in the dentate gyrus region of the male rat hippocampus.Calcium-permeable AMPA receptors in the nucleus accumbens regulate depression-like behaviors in the chronic neuropathic pain state.Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication.NMDA antagonists under investigation for the treatment of major depressive disorder.Perfusion deficits, inflammation and aging precipitate depressive behaviour.New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs.mTOR signaling contributes to motor skill learning in mice.Effects of escitalopram and paroxetine on mTORC1 signaling in the rat hippocampus under chronic restraint stress.Synaptic alterations associated with depression and schizophrenia: potential as a therapeutic target.Dynamic Regulation of AMPAR Phosphorylation In Vivo Following Acute Behavioral Stress.MicroRNAs as biomarkers for major depression: a role for let-7b and let-7c.Radiosynthesis of [18F]ATPFU: a potential PET ligand for mTOR.Chronic Fluoxetine Treatment Upregulates the Activity of the ERK1/2-NF-κB Signaling Pathway in the Hippocampus and Prefrontal Cortex of Rats Exposed to Forced-Swimming Stress.Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit.Rapamycin blocks the antidepressant effect of ketamine in task-dependent manner.Creatine, Similar to Ketamine, Counteracts Depressive-Like Behavior Induced by Corticosterone via PI3K/Akt/mTOR Pathway.Circadian variations in behaviors, BDNF and cell proliferation in depressive mice.Stress and corticosterone increase the readily releasable pool of glutamate vesicles in synaptic terminals of prefrontal and frontal cortex.
P2860
Q21129276-E622839C-CC6D-4264-BB56-FB267412950AQ26777019-DF9E2B8B-4361-4807-8C84-D2F68DC927FDQ33604879-A59B4B7F-9AB8-43E5-8FDC-DD4CA4EFE64BQ33736580-AFCD86F7-A5A7-4B82-B857-D26CB8B4A368Q33812937-CE1ACEC6-632A-4D23-BD00-3324FCF49914Q33874356-660D7A36-315D-4A0C-A159-7918FE7FACA5Q34390309-6C91327F-B3BE-4357-9FEE-0F179BBFD9F0Q35165267-75C8DD93-F066-4142-A32A-55E3FF0DC212Q35657945-399ADA80-F485-4E4E-8D5B-43D3D1EF2231Q35838089-85289824-8F1C-4117-BB4E-8253EBC516ABQ35938248-C799E77E-C4F0-40C8-9E89-BE12DD190065Q36095093-6BDFDC5D-33E9-4660-9712-C7CAE340F3ABQ36237851-641FC39A-213B-49CC-B7C3-7EC91F30DBA6Q36851570-74F2EF29-A16A-44BF-B8D7-DB0C5114D07AQ36927790-DD14B734-5B84-4806-B027-EB01A058E520Q37110924-F7262BBE-E665-4BA9-99FE-7BE3E10BEAFBQ37345192-88C39465-4D15-4C02-9912-EBEC430269B4Q38122158-8583CFD2-2326-4695-9E3C-CE052AC6B58AQ38211107-E7668396-696D-433F-8F0C-FB23DF235A19Q38230661-5EEF8A84-3E09-49FB-879F-91ADB81AA2DAQ38650284-AA7EDEBE-9FD8-45A7-9AF6-98E8938891A0Q38688038-EAC271F8-7078-4406-ADA5-6CD75218AB09Q38818235-824D2381-4BC4-438A-B3A6-82027A384858Q38831859-9A4EF0BE-90EC-4AE6-B5EC-BB44BB2C2564Q40057250-B880A48D-6349-4E9B-9E9C-888CF6DDDBA3Q41084643-0171E05E-F86F-4B7C-91FC-0E7F8B11E03BQ42092288-D2D6B980-B550-47AB-910A-C292E25DCA8CQ42755980-AE935E97-DBE9-4384-8DAE-0069515CAC20Q47306135-D1272270-7AD0-449D-A7C2-FCC20B513692Q47448148-CC69152F-E11C-4F6B-8DC7-647F34A11C2AQ47616820-0D73A9D2-C699-4D3E-9506-55841106E462Q48078182-2FABE7DC-C31B-4611-B864-5F6B97449249Q50687949-6C12D427-DBE9-42A7-BE5D-27FC4EC54B92
P2860
Reduced phosphorylation of the mTOR signaling pathway components in the amygdala of rats exposed to chronic stress.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Reduced phosphorylation of the ...... ats exposed to chronic stress.
@ast
Reduced phosphorylation of the ...... ats exposed to chronic stress.
@en
type
label
Reduced phosphorylation of the ...... ats exposed to chronic stress.
@ast
Reduced phosphorylation of the ...... ats exposed to chronic stress.
@en
prefLabel
Reduced phosphorylation of the ...... ats exposed to chronic stress.
@ast
Reduced phosphorylation of the ...... ats exposed to chronic stress.
@en
P2093
P2860
P1476
Reduced phosphorylation of the ...... ats exposed to chronic stress.
@en
P2093
Abiye H Iyo
Agata Chandran
Beata Karolewicz
Beata Legutko
Courtney S Jernigan
Mark C Austin
P2860
P304
P356
10.1016/J.PNPBP.2012.08.001
P577
2012-08-07T00:00:00Z